Alleghany Corp (Y) Fundamental Analysis & Valuation

NYSE:YUS0171751003

Current stock price

847.79 USD
0.01 (0%)
At close:
847.79 USD
0 (0%)
After Hours:

This Y fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. Y Profitability Analysis

1.1 Basic Checks

  • In the past year Y was profitable.
  • In the past year Y had a positive cash flow from operations.
Y Yearly Net Income VS EBIT VS OCF VS FCFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

1.2 Ratios

Industry RankSector Rank
ROA 1.15%
ROE 4.49%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
Y Yearly ROA, ROE, ROICY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

  • In the last couple of years the Profit Margin of Y has grown nicely.
  • Y's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.78%
PM (TTM) 3.02%
GM N/A
OM growth 3Y84.52%
OM growth 5Y23.94%
PM growth 3Y197.01%
PM growth 5Y17.76%
GM growth 3YN/A
GM growth 5YN/A
Y Yearly Profit, Operating, Gross MarginsY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 5 10 15

2

2. Y Health Analysis

2.1 Basic Checks

  • Y does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for Y has been reduced compared to 1 year ago.
  • The debt/assets ratio for Y is higher compared to a year ago.
Y Yearly Shares OutstandingY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M
Y Yearly Total Debt VS Total AssetsY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10B 20B 30B

2.2 Solvency

  • Y has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
  • A Debt/Equity ratio of 0.30 indicates that Y is not too dependend on debt financing.
  • Although Y's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Altman-Z N/A
ROIC/WACCN/A
WACC7.59%
Y Yearly LT Debt VS Equity VS FCFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Y Growth Analysis

3.1 Past

  • Y shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.36%, which is quite impressive.
  • Y shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.09% yearly.
  • Looking at the last year, Y shows a quite strong growth in Revenue. The Revenue has grown by 12.10% in the last year.
  • Measured over the past years, Y shows a quite strong growth in Revenue. The Revenue has been growing by 14.21% on average per year.
EPS 1Y (TTM)43.36%
EPS 3Y41.72%
EPS 5Y9.09%
EPS Q2Q%-0.63%
Revenue 1Y (TTM)12.1%
Revenue growth 3Y19.03%
Revenue growth 5Y14.21%
Sales Q2Q%-11.07%

3.2 Future

  • Based on estimates for the next years, Y will show a very strong growth in Earnings Per Share. The EPS will grow by 37.33% on average per year.
  • The Revenue is expected to decrease by -26.54% on average over the next years. This is quite bad
EPS Next Y53.69%
EPS Next 2Y37.84%
EPS Next 3Y37.04%
EPS Next 5Y37.33%
Revenue Next Year-62.15%
Revenue Next 2Y-36.68%
Revenue Next 3Y-30.32%
Revenue Next 5Y-26.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
Y Yearly Revenue VS EstimatesY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
Y Yearly EPS VS EstimatesY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

4

4. Y Valuation Analysis

4.1 Price/Earnings Ratio

  • Y is valuated correctly with a Price/Earnings ratio of 15.90.
  • Y's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.71.
  • Y is valuated reasonably with a Price/Forward Earnings ratio of 10.05.
  • When comparing the Price/Forward Earnings ratio of Y to the average of the S&P500 Index (38.09), we can say Y is valued rather cheaply.
Industry RankSector Rank
PE 15.9
Fwd PE 10.05
Y Price Earnings VS Forward Price EarningsY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.68
EV/EBITDA 7.61
Y Per share dataY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

  • Y's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • Y's earnings are expected to grow with 37.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)1.75
EPS Next 2Y37.84%
EPS Next 3Y37.04%

0

5. Y Dividend Analysis

5.1 Amount

  • No dividends for Y!.
Industry RankSector Rank
Dividend Yield N/A

Y Fundamentals: All Metrics, Ratios and Statistics

Alleghany Corp

NYSE:Y (10/18/2022, 8:22:38 PM)

After market: 847.79 0 (0%)

847.79

0.01 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-04
Earnings (Next)11-11
Inst Owners0.02%
Inst Owner Change0%
Ins Owners0.58%
Ins Owner Change0%
Market Cap11.41B
Revenue(TTM)11.75B
Net Income(TTM)355.27M
Analysts48
Price Target864.98 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.25%
Min EPS beat(2)-2%
Max EPS beat(2)18.49%
EPS beat(4)3
Avg EPS beat(4)22.87%
Min EPS beat(4)-2%
Max EPS beat(4)73.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.9
Fwd PE 10.05
P/S 0.97
P/FCF 5.68
P/OCF 5.5
P/B 1.44
P/tB 1.82
EV/EBITDA 7.61
EPS(TTM)53.33
EY6.29%
EPS(NY)84.35
Fwd EY9.95%
FCF(TTM)149.26
FCFY17.61%
OCF(TTM)154.08
OCFY18.17%
SpS872.92
BVpS587.62
TBVpS467.02
PEG (NY)0.3
PEG (5Y)1.75
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 4.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.78%
PM (TTM) 3.02%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y84.52%
OM growth 5Y23.94%
PM growth 3Y197.01%
PM growth 5Y17.76%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Debt/EBITDA N/A
Cap/Depr 35.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 565.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)32.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)411.12%
Profit Quality(5y)537.55%
High Growth Momentum
Growth
EPS 1Y (TTM)43.36%
EPS 3Y41.72%
EPS 5Y9.09%
EPS Q2Q%-0.63%
EPS Next Y53.69%
EPS Next 2Y37.84%
EPS Next 3Y37.04%
EPS Next 5Y37.33%
Revenue 1Y (TTM)12.1%
Revenue growth 3Y19.03%
Revenue growth 5Y14.21%
Sales Q2Q%-11.07%
Revenue Next Year-62.15%
Revenue Next 2Y-36.68%
Revenue Next 3Y-30.32%
Revenue Next 5Y-26.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.38%
FCF growth 3Y68.09%
FCF growth 5Y18.55%
OCF growth 1Y143.87%
OCF growth 3Y66.59%
OCF growth 5Y18.6%

Alleghany Corp / Y Fundamental Analysis FAQ

What is the fundamental rating for Y stock?

ChartMill assigns a fundamental rating of 3 / 10 to Y.


Can you provide the valuation status for Alleghany Corp?

ChartMill assigns a valuation rating of 4 / 10 to Alleghany Corp (Y). This can be considered as Fairly Valued.


What is the profitability of Y stock?

Alleghany Corp (Y) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for Y stock?

The Price/Earnings (PE) ratio for Alleghany Corp (Y) is 15.9 and the Price/Book (PB) ratio is 1.44.


What is the financial health of Alleghany Corp (Y) stock?

The financial health rating of Alleghany Corp (Y) is 2 / 10.